Indicated for adult and pediatric patients with solid tumors that: 🔹 NTRK Fusion: Harbor a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion. 🔹 Condition: Are metastatic or where surgical resection involves severe morbidity, and there are no satisfactory alternative treatments. 🔹 Applicability: Broad range of cancers including sarcomas, lung cancer, thyroid cancer, and colon cancer.

Dosage and administration

Packaging: 100 mg capsules. ⚠️ ADMINISTRATION PROTOCOL: Standard Adult Dose: 100 mg orally twice daily. Usage: Take 1 capsule (100 mg) in the morning and 1 in the evening. Food Intake: Can be taken with or without food. Administration: Swallow whole with water. Do not chew or crush. Supply: One pack (30 caps) provides a 15-day supply at the standard dosage.

Hypersensitivity to Larotrectinib. Pregnancy (can cause fetal harm). Breastfeeding (should be discontinued). Caution required with strong CYP3A4 inhibitors or inducers.

Common adverse reactions include: 🧠 Neurologic: Dizziness (very common), fatigue, paresthesia. 🩸 Hepatic: Increased liver enzymes (ALT/AST levels need monitoring). 📉 Gastrointestinal/Physical: Nausea, vomiting, constipation, weight gain. ⚠️ Advisory: Patients should avoid driving or operating machinery if they experience dizziness.

Laronib 100 — Larotrectinib 100 mg, 30 pcs, Everest

100% original product

Active ingredient

Larotrectinib

Manufacturer

Everest

Dosage 100 mg

Dosage form Capsules

Capsules per pack 30

Laronib 100 (Larotrectinib) 100 mg Capsules

Name: Laronib 100
Brand: Everest
SKU: PROD-150
Price: 39115 UAH
Availability: InStock

39115₴ ~~43949₴~~ -11%

Laronib 100 mg (Larotrectinib) is a potent, highly selective TRK inhibitor used for the treatment of cancers driven by specific genetic alterations.

Manufacturer: Everest Pharmaceuticals. Each pack contains 30 capsules. It is a precision oncology drug that targets tumors with NTRK gene fusions regardless of the tumor's location in the body (tissue-agnostic).

Key Feature:

This 100 mg capsule is the standard adult strength, offering deep and durable responses in patients with NTRK fusion-positive solid tumors.

Indicated for adult and pediatric patients with solid tumors that:

🔹 NTRK Fusion: Harbor a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion.
🔹 Condition: Are metastatic or where surgical resection involves severe morbidity, and there are no satisfactory alternative treatments.
🔹 Applicability: Broad range of cancers including sarcomas, lung cancer, thyroid cancer, and colon cancer.

Packaging: 100 mg capsules.

⚠️ ADMINISTRATION PROTOCOL:

Standard Adult Dose: 100 mg orally twice daily.
Usage: Take 1 capsule (100 mg) in the morning and 1 in the evening.
Food Intake: Can be taken with or without food.
Administration: Swallow whole with water. Do not chew or crush.
Supply: One pack (30 caps) provides a 15-day supply at the standard dosage.

Hypersensitivity to Larotrectinib.
Pregnancy (can cause fetal harm).
Breastfeeding (should be discontinued).
Caution required with strong CYP3A4 inhibitors or inducers.

Common adverse reactions include:

🧠 Neurologic: Dizziness (very common), fatigue, paresthesia.
🩸 Hepatic: Increased liver enzymes (ALT/AST levels need monitoring).
📉 Gastrointestinal/Physical: Nausea, vomiting, constipation, weight gain.
⚠️ Advisory: Patients should avoid driving or operating machinery if they experience dizziness.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 18.03.2026

Active ingredient

Larotrectinib

Manufacturer

Everest

Dosage 100 mg

Dosage form Capsules

Capsules per pack 30

100% original product

Delivery across Ukraine

Alternatives

What Customers Say

No reviews yet

Your review can be the first!

Laronib 100 (Larotrectinib) 100 mg Capsules

Similar products

Laronib 25

What Customers Say

No reviews yet

Contact us

Request a call